(Short version) Critical Medicines Act: delivering a secure supply of critical medicines and active pharmaceutical ingredients in Europe

27 January 2025

Report

Market Access Barriers: An overview of key barriers to generic and biosimilar market entry in select EU trading partners

31 October 2024

Report

Critical Medicines Act: delivering a secure supply of critical medicines and active pharmaceutical ingredients in Europe

25 September 2024

Report

A new transatlantic partnership for the secure supply of medicines

15 July 2024

Report

Beneath the Surface: Unravelling the True Value of Generic Medicines – IQVIA

10 April 2024

Report

Today, generic medicines are an integral part of the healthcare […]

Review of Nitrosamine Drug Substance Related Impurities (NDSRI) in Pharmaceutical Drugs

30 October 2023

Report

Biosimilars Market Review 2023

18 September 2023

Report

Generic Market Review 2023

29 June 2023

Report

Review of the SPC Manufacturing Waiver: a First Industry Report

13 June 2023

Report

A Strong European API Industry Can Achieve Strategic Autonomy of the EU Health System

9 November 2022

Report